All News

heart.jpg (keep)

High CV Risk in Lupus

d RheumNow

Patients with systemic lupus erythematosus (SLE) remain at risk for accelerated atherosclerosis, and important questions have yet to be answered, British investigators reported.

Read Article
falls.jpg (keep)

Trazodone High Risk of Falls and Fractures

d Jack Cush, MD

The CMAJ (Canadian Medical Association Journal) has reported that trazadone use in the elderly may be associated with a risk of falls and major fractures. 

Read Article
TB Testing 2 - Note: <10% of pts initially PPD/IGRA neg may be positive later (either they were anergic or have a new TB infx). I Recommend repeat TB testing 3 mos after starting or changing from 1st to 2nd biologic - Repeat testing indicated if newly EXPOSED or when Risk Changes

Dr. John Cush RheumNow ( View Tweet)

TB Testing - Do PPD or IGRA before TNFi or biologic - If negative, start therapy - If Positive, Eval for active TB (Sxs, CXR, C/S); if neg --> LTBI Rx BEFORE biologic - If "Indeterminate", repeat or change test. If same or neg--> start biologic - Do not do annual TST or IGRA

Dr. John Cush RheumNow ( View Tweet)

Metanalysis shows DMARDs (6 studies) and biologics (5 studies) offer NO clinically significant benefit compared with placebo in Osteoarthritis. https://t.co/fNGVzuNQNo

Links:

Dr. John Cush RheumNow ( View Tweet)

Vasculopathy (inflammatory, occlusive, necrotizing) distguishes juvenile dermatomyositis from adult myositis - also w/ high risk of severe extra-muscular dz (GI, Lung, cardiac, skin). Good review article here https://t.co/yH8xwKl6S8

Links:

Dr. John Cush RheumNow ( View Tweet)

Could routine use of hydroxychloroquine reduce the rate of serious infections in immunosuppressed patients? A modest to moderate risk reduction noted in two large SLE cohort studies. https://t.co/pssLrteRRq

Links:

Dr. John Cush RheumNow ( View Tweet)

2018 NRMP report shows Rheumatology as one of the most competitive fellowships with 313 applicants for 221 positions - 147 filled by US grads and 69 by FMGs. https://t.co/xRmMyA2yCy

Links:

Dr. John Cush RheumNow ( View Tweet)

Clinical Trials Benchmark for Biosimilar Development is one of several educational videos available in the "Therapeutic Update: Biosimilars in Rheumatology" video series, sponsored by Sandoz, Inc. and now available on RheumNow. https://t.co/1vmnEJqOSi

Links:

Dr. John Cush RheumNow ( View Tweet)

J Rheum (Ward et al) reports that the minimal clinically important improvement (MCII) of RAPID-3 was –3.8. https://t.co/UxCOeMl52g

Links:

Dr. John Cush RheumNow ( View Tweet)

The "Type" of person you are often is displayed with how you manage authority

Dr. John Cush RheumNow ( View Tweet)

CORRECTION: mm! Guidelines on CT pulm nodules-no F/U needed for solid nodules <6mm in low risk pts (age,smoking, morphology); but larger (6-8mm), suspicious nodules should have 6 & 12 mos F/U images. Some 8cm or more nodules require more freq assessments https://t.co/Nl6zV3VQg1

Links:

Dr. John Cush RheumNow ( View Tweet)

“This is not your responsibility but it is your problem.” — Cheryl Strayed I believe the converse is more important to what we need to teach our patients - "This is not just your problem, this is now your responsibility"

Dr. John Cush RheumNow ( View Tweet)

Safety and Immunogenicity is one of nine educational videos available in the "Therapeutic Update: Biosimilars in Rheumatology" video series, sponsored by Sandoz, Inc. and now available on RheumNow. https://t.co/1vmnEJqOSi

Links:

Dr. John Cush RheumNow ( View Tweet)

FDA Approves Gamifant (emapalumab-lzsg) for Primary Hemophagocytic Lymphohistiocytosis https://t.co/YALlc0XdKh

Links:

Dr. John Cush RheumNow ( View Tweet)

Are you a US rheumatologist interested in what the midterm election results mean for us? 100 members of the next Congress are NEW and we need to meet them! Please invest in #RheumPAC NOW. Help advance arthritis research, reform step therapy & other causes! https://t.co/pcRkh6eLfJ

Links:

Angus Worthing MD AngusWorthing ( View Tweet)

Sudden discontinuation of duloxetine may have Adverse Events in up to 44% - dizziness, nauseam headache, paresthesia, vomiting, irritability, nightmares. Instead, its rec to gradually reduce dose over 2 weeks before D/C of duloxetine.https://t.co/aSGU0CVldB

Links:

Dr. John Cush RheumNow ( View Tweet)

New Guidelines on CT pulm nodules-no F/U needed for solid nodules <6cm in low risk pts (age, smoking, morphology); but larger (6-8cm), suspicious nodules should have 6 and 12 mos F/U images. Some 8cm or more nodules require more freq assessments https://t.co/Nl6zV3VQg1

Links:

Dr. John Cush RheumNow ( View Tweet)

The Next Best Meeting in Rheumatology is coming - RHEUMNOW LIVE - March 22-24 2019 in beautiful downtown Fort Worth. Short Lectures, interactive sessions, Q&A panels, TED (like) Talks, digital, streaming and much more. You dont want to miss this meeting! https://t.co/5TVg0Frsbf

Links:

Dr. John Cush RheumNow ( View Tweet)

79 pts Ultrasound evidence of gout (tophus or double contour sign) @ knee or MTP1 were given ULT for 6 mos. Those achieving very low uric acid levels showed US decrease in tophus (r = 0.54) and double contour sign disappearance (r=−0.59) https://t.co/4W0EX8swDo

Links:

Dr. John Cush RheumNow ( View Tweet)

×